Slide 1: Investors Presentation: Financial results for H1 2025
INVESTORS PRESENTATION Financial results for H1 2025
Slide 2: Speakers
SPEAKERS
Slide 3: Contents
CONTENTS 01 About Norofert 04 Agribusiness Market Context Projects and Investments 02 05 Norofert Strategy 03 H1 2025 Results 06 Contact
Slide 4: About Norofert
About Norofert 01
Slide 5: Norofert – the leader in research for regenerative agriculture
Own production capabilities for agricultural inputs and farming 85 Products in portfolio Norofert – the leader in research 4 Business Lines for regenerative agriculture and one of the largest input producers in Romania, currently expanding its production facilities to support sustainable 12.000 lite
Slide 6: Norofert's History
NOROFERT’s History M&A – acquisition of a 1,000-hectare farm in Zimnicea, Teleorman County, and a production Completion of an irrigation system at the Zimnicea farm facility in Filipeștii de Pădure. covering an area of Private placement 340 hectares. A new line of granular fertilizers for soil appli
Slide 7: Management Team
MANAGEMENT TEAM Vlad Popescu MIRCEA FULGA President of the Board CEO Vlad Popescu has been involved in Mircea Fulga joined the Norofert team in agriculture and in Norofert since 2011. He February 2020 as Director of Research and began his activity in the company by Development – Bio Division. delive
Slide 8: Norofert Product Portfolio
yy NOROFERT PRODUCT PORTFOLIO
Slide 9: Own Production Capacities, 85 Products
OWN PRODUCTION CAPACITIES 12,000 liters/ day 45,000 liters/ day 4,000 liters/ week 85 PRODUCTS NOROFERT NOROFERT NOROFERT ORGANICS Developed in our own ORGANICS FITO Horticulture Hobby gardening laboratory NOROFERT NOROFERT NOROFERT NOROFERT READY TO USE GRANULATED POWER MIX POWER TEK
Slide 10: Norofert's Projects and Investments
Norofert’s Projects and Investments 02
Slide 11: Norofert Investments
NOROFERT INVESTMENTS 2024 RON 26.7 million total investments in the last 5 years 2022 2023 2019 2025 Acquisition of property in Development of the research and Filipeștii de Pădure microorganism multiplication laboratory in Filipeștii de Pădure / Phase 1 RON 5 mil. RON 5 mil. Installation of irrigat
Slide 12: Investments in Irrigation at Zimnicea Farm
INVESTMENTS IN IRRIGATION AT ZIMNICEA FARM Existing irrigation systems: pivot irrigation systems covering approximately 650 ha; Future irrigation systems: 700 ha by the end of 2025; Long-term vision: • Full water control for the entire cultivated area of 1,000 ha; • Optimization of agricultural proc
Slide 13: International Market Expansion: United States of America
INTERNATIONAL MARKET EXPANSION UNITED STATES OF AMERICA (USA) The products sold by Production: soil health Norofert AG LLC are 2021 - 2023 and foliar nutrition entirely manufactured at 2021 - 2023 range. the factory in Watertown, Assembly of the production South Dakota, and all other 2020 Product re
Slide 14: International Market Expansion: Brazil
INTERNATIONAL MARKET EXPANSION BRAZIL 2024 Signing of the strategic Replication of the technical The production line will partnership. Start of the model implemented in South 2023 become operational in the Bacteria produced in the construction of the Dakota, USA. Production second half of 2025 and w
Slide 15: H1 2025 Results
H1 2025 Results 03
Slide 16: Evolution Key Figures H1 2025 vs H1 2024
EVOLUTION KEY FIGURES H1 2025 vs H1 2024 H1 2024 H1 2025 H1 2024 H1 2025 OPERATING INCOME OPERATING INCOME (11.77)% OPERATING INCOME OPERATING INCOME (9.65)% RON 25.12 mil. RON 22.16 mil. RON 24.38 mil. RON 22.03 mil. TURNOVER TURNOVER (9.55)% TURNOVER TURNOVER (9.88)% RON 21.04 mil. RON 19.03 mil.
Slide 17: Evolution Key Figures
EVOLUTION KEY FIGURES Profit and loss statement in RON mil. 40 34.21 35 29.90 30 27.68 26.44 25.14 25 22.84 23.07 22.19 20.18 21.04 20 19.03 18.54 15 10 6.52 5 3.61 3.64 2.06 0 Turnover Total income Total expenses Gross result H1 2022 H1 2023 H1 2024 H1 2025 17
Slide 18: Consolidated Financial Results
CONSOLIDATED FINANCIAL RESULTS Income Statement Indicators – RAS Consolidated • In H1 2025, consolidated operating revenues reached RON 22.16 million, down by 11.77% compared to H1 2024. 30.06.2025 Variation • Norofert Group ended H1 2025 with a RON mil. 30.06.2024 turnover of RON 19.03 million, dow
Slide 19: Consolidated Financial Results
CONSOLIDATED FINANCIAL RESULTS Selected balance sheet positions – RAS Consolidated RON mil. 30.06.2024 30.06.2025 Variation • In H1 2025, the Group’s fixed assets balance increased by 9.9% to a total of RON 30.4 Fixed assets 27,664,139 30,402,944 9.90% million, this growth being mainly due to the Cu
Slide 20: Individual Financial Results Norofert AG LLC
INDIVIDUAL FINANCIAL RESULTS NOROFERT AG LLC Income statement indicators – RAS Selected balance sheet positions – RAS RON mil. 30.06.2025 RON mil. 30.06.2025 Fixed assets 208,912 Current assets 800,717 Turnover 1,785,149 Inventories 364,788 Operating income 1,785,149 Trade receivables 425,210 Operat
Slide 21: Agribusiness Market Context
Agribusiness Market Context 04
Slide 22: Recent Developments in the Agribusiness Market
RECENT DEVELOPMENTS IN THE AGRIBUSINESS MARKET Rising demand for The contribution of the organic products agribusiness sector to Romania’s economy Global consumers are showing increasing interest in organic The agribusiness sector has a products, with the market significant contribution to projected
Slide 23: Recent Developments in the Agribusiness Market
RECENT DEVELOPMENTS IN THE AGRIBUSINESS MARKET Total agricultural area in Romania (million hectares) Evolution of organic farming areas in Romania, % of total agricultural land 800 5.46% 6% Thousands 5.07% 700 4.42% 5% 600 3.59% 4% 500 2.86% 400 2.43% 3% 13.8 694 300 645 13.4 579 2% 13.05 13.08 469
Slide 24: Norofert Strategy
Norofert Strategy 05
Slide 25: Strategic Pillars
2 STRATEGIC PILLARS PILLAR I – DEVELOPMENT OF ADAPTABLE SOLUTIONS PILLAR II – INTERNATIONAL THROUGH CONTINUOUS EXPANSION INNOVATION Development and launch of at Presence in at least 3–5 new least three new innovative markets in the coming years. biotechnology solutions over the next three years.. 25
Slide 26: EGMS for share capital increase
EGMS for share capital increase Norofert has convened the Extraordinary General Meeting of Shareholders (EGMS) for October 9, 2025. On the agenda is also the approval of the share capital increase, with the following objectives: • Supporting strategic investments, particularly in the development of
Slide 27: Why invest in Norofert
Consolidated position in an emerging market segment. Why invest in Agro-tech profile with research-development- innovation activity => sustainable business growth and attractiveness for investors. Norofert Continuous innovation, complete product range, proven efficiency, competitive prices closely a
Slide 28: Contact Details
Email CONTACT DETAILS Street. LT.AV. Șerban Petrescu, No.20, District 1, Bucharest www.norofert.ro investitori@norofert.ro 0753 157 858